Committed to the Health and Well-Being of the Community
09. December 2024.
Over the course of 2024, Hemofarm achieved excellent business results and confirmed its leadership position on the market. Impressive data also come from Hemofarm's plants in Serbia, BiH and Montenegro, where almost 8 billion tablets were produced.

“This year has been extremely important for Hemofarm. As a regional leader, we continued our journey of innovations and growth and influenced the improvement of health protection and sustainable development. We continue with investments in modernization and improvement of manufacturing capacities that make Hemofarm one of the most significant players on the pharmaceutical market of the region”, said CEO of Hemofarm, Ronald Seeliger at a festive event for business partners and associates.



In the area of sustainable development, this year Hemofarm has organized the first ESG festival, with more than 65 representatives of institutions, companies and non-governmental organizations. The aim of the festival is to raise the awareness and understanding of sustainable development, as well as to improve the cooperation between the academic, business and social communities.

’We want to share our experience and motivate others to join us on the way to a sustainable future. In our commitment to the health and well-being of the community, we are developing initiatives with our partners that will have a lasting impact’ Seeliger added.

In 2024 Hemofarm, Hemofarm Foundation and Ministry of Health continued jointly the campaign „The Most Important Call in Life“, aimed at raising awareness on the significance of organ donation.



Through the drive „Start from Yourself“, in Bosnia and Herzegovina, the company supports parents houses in which children suffering from malignant diseases and their parents stay during treatment, and global movement Movember was supported also this year by Mustache Guys from Hemofarm with the message: Examine yourself!

The year nearing its end was also marked by the jubilee of Hemomont in Montenegro, which celebrated 30 years of successful business, confirming its place as a reliable partner in the pharmaceutical industry.

In the coming period, Hemofarm plans further growth and innovations, with a clear focus on social responsibility, as well as improving the quality of life of patients throughout the region. As the largest exporter of pharmaceutical products from Serbia, Hemofarm is present in over 30 markets worldwide and employs almost four and a half thousand people. As a member of the STADA Group, Hemofarm continues to grow and develop, strengthening Serbia's position on the global pharmaceutical market.